Glucagon-like peptide-1 (GLP-1) receptor agonists (also called “glutides”) are an effective treatment for patients with type 2 diabetes and chronic kidney disease In a randomized controlled trial of ...
Apollo Therapeutics Group Ltd. and Sunshine Lake Pharma Co. Ltd. inked a potential $938 million licensing deal for APL-18881 (HEC-88473), Sunshine’s dual fibroblast growth factor 21 ...